Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid Dosing Regimens after DMEK
NCT01448213Phase 2Completed
- Sponsor
- Price Vision Group
- Start
- Oct 2011
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of fluorometholone in corneal transplant rejection, sponsored by Price Vision Group. Started Oct 2011; status: completed.
02
Drugs
fluorometholone
03
Conditions
corneal transplant rejection
Beyond the preview
Go deeper on NCT01448213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448213.